Dr. Akila Viswanathan and Dr. Jean Wright discuss the most recent recommendations for treating breast cancer with radiation.
Dr. Brandi Page presents a head and neck cancer case that demonstrates the benefits of proton therapy and Johns Hopkins' multidisciplinary approach to treatment.
Dr. Susan Scott, a fellowship-trained medical oncologist, uses advanced treatments for cancer patients, including early phase clinical trials, targeted therapies and immunomodulation in lung tumors.
In this short video, Haniee Chung, fellowship-trained colorectal surgeon, discusses the importance of the tri-modality approach to treating colorectal cancers, total neoadjuvant therapy for rectal cancers and the importance of sphincter-sparing surgery.
Surgical oncologist David Euhus explains how and when genetic testing for patients with breast cancer performed at Johns Hopkins, how this process has been streamlined to get results faster and shares how genetic testing will look like in the future.
Surgical oncologist Christopher Shubert and medical oncologist Mark Yarchoan discuss the latest research advancements and treatment options for liver and biliary cancer patients within the Johns Hopkins Liver and Biliary Multidisciplinary Clinic.
Dr. Jeanine Staples, a fellowship-trained gynecologic oncology surgeon, uses advanced minimally invasive techniques to treat patients, maintain positive outcomes and reduce complications.
Dr. Jean Wright, fellowship trained radiation oncologist, discusses treatment options for breast cancer, including the use of proton therapy for left breast cancer, and how the multidisciplinary team at Johns Hopkins manages all breast cancer cases.
Dr. Curtiland Deville presents a lung tumor case that demonstrates the benefits of organ sparing proton therapy compared to photon therapy.
The latest techniques in prostate radiation treatment are currently at Sibley. Learn about how technology and clinical trials are helping to improve care.
With the rise of COVID-19, Johns Hopkins neurosurgeon Chetan Bettegowda started looking at how cancer immunotherapies could play a role in the treatment of cytokine storms being seen in patients with COVID-19.
A Chinese patient initially diagnosed with lung cancer traveled to Johns Hopkins for a second opinion. Noticing inconsistencies in the patient’s scans, experts brought her case to the gastrointestinal tumor board.
Dr. Karim Boudadi discusses his techniques and use of the most advanced options to treat head and neck cancer.
Surgical oncologist Jonathan Greer discusses the case of a patient with colon cancer and Lynch syndrome, a genetic predisposition to different cancer types, who underwent a complex HIPEC procedure to treat the cancer.
Dr. Akila Viswanathan talks with Dr. Jean Wright from Sibley Memorial Hospital about treating breast cancer.
Surgical oncologist, Fabian Johnston details the case of a patient with a CDH1 mutation - a rare genetic defect that often requires advanced screening methods to detect and greatly increases a patient’s chances of developing gastric cancer.
Curtiland Deville, MD, compares photon and proton treatment options in lung and sarcoma cases.
Dr. Akila Viswanathan speaks with Dr Curt Deville from Sibley Memorial Hospital in Washington DC about the diagnosis and treatment of prostate cancer and the opening of the Johns Hopkins National Proton Center coming to Sibley later this year.
Caoilfhionn Connolly and colleagues assessed patients with inflammatory arthritis from cancer-treating checkpoint inhibitors to see what has an impact on their quality of life and what type of symptoms patients experience. They found that ...
In the latest podcast from Kimmel Cancer Center Director Dr Bill Nelson, he speaks with Dr Khaled El-Shami about treating leukemia and the growing hematologic program at Sibley Memorial Hospital in Washington DC.
Finding ways to make cancer cells unable to spread, and ways to make other organs less fertile for cancer to take root.
Learn how microvascular and facial plastic reconstructive surgeon Shaun Desai conducted a complex, two-stage nasal reconstruction after the surgical removal of a woman’s Merkel cell carcinoma.
Dr Bill Nelson talks with Dr Ben Levy, the Clinical Director of Medical Oncology at Sibley Memorial Hospital, about new treatments for lung cancer patients and the growing cancer center at Sibley.
Dr Bill Nelson speaks with Dr Karim Boudadi from Sibley Memorial Hospital about the multiple treatment options for HPV related head and neck cancers.
Dr Ben Levy and thoracic surgeon Stephen Broderick discuss the important aspects of lung cancer surgery, including how surgical techniques are advancing, how patients should prepare in advance and what to expect during recovery.
Dr Bill Nelson talks with Dr Jean Hoffman-Censits and Dr Armine Smith, from the Johns Hopkins Greenberg Bladder Cancer Institute, about the complications that arise in diagnosing and treating bladder cancer in women.
Kenneth Cooke, director of the Johns Hopkins Kimmel Cancer Center Pediatric Bone Marrow Transplantation Program, shares innovative treatments of half-matched related donor transplants at Johns Hopkins and discusses how half-match is influencing patient care.
Dr. Matthew Ladra discusses proton therapy for pediatric patients. Dr. Ladra leads the dedicated pediatric team at the Johns Hopkins Proton Therapy Center, in collaboration with Children’s National Hospital.
Dr. Stephanie Terezakis and her research team are looking for ways to deliver radiation more precisely to tumors and minimize radiation to healthy tissues.
An animation explaining the pancreatic auto islet transplantation process with complete removal of the pancreas to treat pancreatitis.
Dr. Li and her team investigate how cells consolidate their damaged proteins and prevent them from spreading freely, in order to understand how to better treat diseases such as Alzheimer’s and ALS.
Nickolas Papadopoulos, Ph.D., and his team at the Ludwig Center at Johns Hopkins are developing a superbly sensitive test for mitosis by interrogating each individual’s molecule sample in patients with early-stage cancer.
Alan Partin, M.D., Ph.D., and his research group develop and test blood, urine and tissue cells to detect prostate cancer early.
Cell biologist Andrew Ewald and his team have discovered what allows breast cancer cells to leave the main tumor and build new tumors in the lungs, bones and brains. Now, their goal is to identify patients whose breast cancer is likely ...
#TomorrowsDiscoveries: Dr. DeWeese and his team are testing a way to target a protein found on the surface of cancer cells, but not non-cancer cells. Their goal is to destroy cancer while protecting normal tissue.
#TomorrowsDiscoveries: Normal brain tissue must be protected while doctors destroy a brain tumor. Researchers at Johns Hopkins are creating new, targeted treatments for brain tumor patients.
Can a custom-built white blood cell avoid suppression by cancer and boost our immune system? Dr. Jonathan Schneck has developed “artificial antigen-presenting cells” and is working to put them to use in the clinic.
Dr. Assaf Gilad is developing new technologies to “tag” stem cells and monitor cell fate with MRI, improving patient safety and treatment outcomes, especially for those with brain cancer and heart disease.
Dr. Gregg Semenza’s team has identified a way to overcome the resistance of cancer stem cells to chemotherapy, completely eradicating breast tumors in mice.
Dr. Elias Zambidis cares for children suffering from leukemia and other blood disorders.
Urologic oncologist Kenneth Pienta and his team are working to identify what keeps disseminated tumor cells asleep or reactivates them so that they can better treat prostate cancer.
Otolaryngologist Carole Fakhry, M.D., discusses the case of a 52-year-old man presenting with a neck and tonsil mass. The patient is doing well after transoral robotic surgery (TORS) and neck dissection were performed, followed by radiation.
Otolaryngologist Carole Fakhry, M.D., discusses the use of transoral robotic surgery (TORS) in the treatment of HPV-related oral pharynx cancer, and how its use can de-intensify and reduce morbidities from typically used adjuvant treatment therapies.
Pediatric neurosurgeon Alan Cohen, M.D., chief of pediatric neurosurgery at Johns Hopkins, discusses the latest advances in the diagnosis and treatment of pediatric brain tumors, including minimally invasive surgery and genetic profiling.
Elizabeth Tracey and William Nelson M.D., director of the Kimmel Cancer Center at Johns Hopkins, discuss the findings from a study recently reported in the New England Journal of Medicine that examined the role germ line mutations play in childhood cancers.
The case of a 68-year-old male with squamous cell carcinoma of the left mandible gingiva, presented by Dr. Alexander Pazoki.
Dr. Jin He, associate professor of surgery, describes the minimally invasive surgical techniques available for patients with liver cancer or a liver tumor, the benefits and who is an ideal candidate.
Chief of surgical oncology Timothy Pawlik, M.D., M.P.H., Ph.D., F.A.C.S.explains types of liver cancer and the advanced treatment options offered at Johns Hopkins, including portal vein embolization and liver resection surgery.
Lonny Yarmus, clinical chief of the Division of Pulmonary and Critical Care Medicine, gives a brief overview on lung cancer screening, including who is a candidate and insurance coverage.
Chetan Bettegowda, M.D., Ph.D., a Johns Hopkins neurosurgeon, discusses his research on a new liquid biopsy to screen asymptomatic people to detect cancers when they are not yet clinically detectable.
Dr. Susan L. Gearhart, MD, FACS, and Dr. Francis Giardiello, MD, present, Colon Cancer: Know Your Risk Factors, Symptoms, and the Importance of Screening and Current Treatments.